TickerFacts.

NRC Health (NRC): EPS (Diluted)

Annual figures by period end, from SEC filings.

$50.00
Year ended 2025-12-31
+240.2%
3-year compound annual growth
+103.0%
5-year compound annual growth
2009-12-31: $1.262010-12-31: $1.262011-12-31: $1.692012-12-31: $2.172019-12-31: $1.262020-12-31: $1.452021-12-31: $1.462022-12-31: $1.272023-12-31: $1.252024-12-31: $1.042025-12-31: $50.00$50.00
2009-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$50.00n/m2026-03-05, From 2025-01-01
2024-12-31$1.04-16.8%2026-03-05, From 2024-01-01
2023-12-31$1.25-1.6%2026-03-05, From 2023-01-01
2022-12-31$1.27-13.0%2025-03-17, From 2022-01-01
2021-12-31$1.46+0.7%2024-02-27, From 2021-01-01
2020-12-31$1.45+15.1%2023-03-03, From 2020-01-01
2019-12-31$1.26n/a2022-03-04, From 2019-01-01
No annual figure between 2012-12-31 and 2019-12-31.
2012-12-31$2.17+28.4%2013-03-01, From 2012-01-01
2011-12-31$1.69+34.1%2013-03-01, From 2011-01-01
2010-12-31$1.260.0%2013-03-01, From 2010-01-01
2009-12-31$1.26n/a2012-03-01, From 2009-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
NRC Health (NRC)2025-12-31$50.00n/m
MaxCyte, Inc. (MXCT)2025-12-31-$0.42n/m
OmniAb, Inc. (OABI)2025-12-31-$0.57n/m
Medpace Holdings, Inc. (MEDP)2025-12-31$15.28+21.0%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$8.66n/m
Charles River Laboratories International, Inc. (CRL)2025-12-27-$2.91n/m
Incyte Corp (INCY)2025-12-31$6.41n/m
Absci Corp (ABSI)2025-12-31-$0.84n/m
Icon PLC (ICLR)2025-12-31$2.90-67.4%

Compare NRC, MXCT, OABI, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗